カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のエンテカビル製剤市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Entecavir Preparations Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7844）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7844
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のエンテカビル製剤市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のエンテカビル製剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のエンテカビル製剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- エンテカビル製剤の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

エンテカビル製剤市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・錠剤、カプセル、分散錠、その他

用途別セグメント
・病院、診療所、その他

主要な市場プレーヤー
・Bristol-Myers Squibb、Qilu Pharmaceutical Co., Ltd、Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd.、JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD.、Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、Suzhou Dawnrays Pharmaceutical Co., Ltd.、Fujian Cosunter Pharmaceutical Co.,Ltd.、Shandong Lukang Pharmaceutical Co.,Ltd.、Aurobindo Pharma、Teva、Hainan Zhonghe Pharmaceutical Co., Ltd、Zhejiang Huasheng Pharmaceutical Group Co., Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エンテカビル製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエンテカビル製剤メーカーの企業概要、2019年～2022年までのエンテカビル製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエンテカビル製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別エンテカビル製剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのエンテカビル製剤のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのエンテカビル製剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびエンテカビル製剤の産業チェーンを掲載しています。
・第14、15章では、エンテカビル製剤の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– エンテカビル製剤の概要
– タイプ別分析（2018年vs2022年vs2029年）：錠剤、カプセル、分散錠、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のエンテカビル製剤市場規模・予測
– 世界のエンテカビル製剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bristol-Myers Squibb、Qilu Pharmaceutical Co., Ltd、Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd.、JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD.、Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、Suzhou Dawnrays Pharmaceutical Co., Ltd.、Fujian Cosunter Pharmaceutical Co.,Ltd.、Shandong Lukang Pharmaceutical Co.,Ltd.、Aurobindo Pharma、Teva、Hainan Zhonghe Pharmaceutical Co., Ltd、Zhejiang Huasheng Pharmaceutical Group Co., Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：錠剤、カプセル、分散錠、その他
・用途別分析2018年-2029年：病院、診療所、その他
・エンテカビル製剤の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・エンテカビル製剤のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・エンテカビル製剤のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エンテカビル製剤の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・エンテカビル製剤の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Entecavir Preparations
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Entecavir Preparations Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Dispersible Tablets
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Entecavir Preparations Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Entecavir Preparations Market Size & Forecast
1.5.1 Global Entecavir Preparations Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Entecavir Preparations Sales Quantity (2018-2029)
1.5.3 Global Entecavir Preparations Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Entecavir Preparations Product and Services
2.1.4 Bristol-Myers Squibb Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bristol-Myers Squibb Recent Developments/Updates
2.2 Qilu Pharmaceutical Co., Ltd
2.2.1 Qilu Pharmaceutical Co., Ltd Details
2.2.2 Qilu Pharmaceutical Co., Ltd Major Business
2.2.3 Qilu Pharmaceutical Co., Ltd Entecavir Preparations Product and Services
2.2.4 Qilu Pharmaceutical Co., Ltd Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
2.3 Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd.
2.3.1 Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Details
2.3.2 Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Major Business
2.3.3 Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Entecavir Preparations Product and Services
2.3.4 Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD.
2.4.1 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Details
2.4.2 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Major Business
2.4.3 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Entecavir Preparations Product and Services
2.4.4 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Recent Developments/Updates
2.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
2.5.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Details
2.5.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Major Business
2.5.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Entecavir Preparations Product and Services
2.5.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
2.6 Suzhou Dawnrays Pharmaceutical Co., Ltd.
2.6.1 Suzhou Dawnrays Pharmaceutical Co., Ltd. Details
2.6.2 Suzhou Dawnrays Pharmaceutical Co., Ltd. Major Business
2.6.3 Suzhou Dawnrays Pharmaceutical Co., Ltd. Entecavir Preparations Product and Services
2.6.4 Suzhou Dawnrays Pharmaceutical Co., Ltd. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Suzhou Dawnrays Pharmaceutical Co., Ltd. Recent Developments/Updates
2.7 Fujian Cosunter Pharmaceutical Co.,Ltd.
2.7.1 Fujian Cosunter Pharmaceutical Co.,Ltd. Details
2.7.2 Fujian Cosunter Pharmaceutical Co.,Ltd. Major Business
2.7.3 Fujian Cosunter Pharmaceutical Co.,Ltd. Entecavir Preparations Product and Services
2.7.4 Fujian Cosunter Pharmaceutical Co.,Ltd. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fujian Cosunter Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.8 Shandong Lukang Pharmaceutical Co.,Ltd.
2.8.1 Shandong Lukang Pharmaceutical Co.,Ltd. Details
2.8.2 Shandong Lukang Pharmaceutical Co.,Ltd. Major Business
2.8.3 Shandong Lukang Pharmaceutical Co.,Ltd. Entecavir Preparations Product and Services
2.8.4 Shandong Lukang Pharmaceutical Co.,Ltd. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shandong Lukang Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Entecavir Preparations Product and Services
2.9.4 Aurobindo Pharma Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aurobindo Pharma Recent Developments/Updates
2.10 Teva
2.10.1 Teva Details
2.10.2 Teva Major Business
2.10.3 Teva Entecavir Preparations Product and Services
2.10.4 Teva Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Teva Recent Developments/Updates
2.11 Hainan Zhonghe Pharmaceutical Co., Ltd
2.11.1 Hainan Zhonghe Pharmaceutical Co., Ltd Details
2.11.2 Hainan Zhonghe Pharmaceutical Co., Ltd Major Business
2.11.3 Hainan Zhonghe Pharmaceutical Co., Ltd Entecavir Preparations Product and Services
2.11.4 Hainan Zhonghe Pharmaceutical Co., Ltd Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hainan Zhonghe Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Zhejiang Huasheng Pharmaceutical Group Co., Ltd.
2.12.1 Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Details
2.12.2 Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Major Business
2.12.3 Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Entecavir Preparations Product and Services
2.12.4 Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Entecavir Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Entecavir Preparations by Manufacturer
3.1 Global Entecavir Preparations Sales Quantity by Manufacturer (2018-2023)
3.2 Global Entecavir Preparations Revenue by Manufacturer (2018-2023)
3.3 Global Entecavir Preparations Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Entecavir Preparations by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Entecavir Preparations Manufacturer Market Share in 2022
3.4.2 Top 6 Entecavir Preparations Manufacturer Market Share in 2022
3.5 Entecavir Preparations Market: Overall Company Footprint Analysis
3.5.1 Entecavir Preparations Market: Region Footprint
3.5.2 Entecavir Preparations Market: Company Product Type Footprint
3.5.3 Entecavir Preparations Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Entecavir Preparations Market Size by Region
4.1.1 Global Entecavir Preparations Sales Quantity by Region (2018-2029)
4.1.2 Global Entecavir Preparations Consumption Value by Region (2018-2029)
4.1.3 Global Entecavir Preparations Average Price by Region (2018-2029)
4.2 North America Entecavir Preparations Consumption Value (2018-2029)
4.3 Europe Entecavir Preparations Consumption Value (2018-2029)
4.4 Asia-Pacific Entecavir Preparations Consumption Value (2018-2029)
4.5 South America Entecavir Preparations Consumption Value (2018-2029)
4.6 Middle East and Africa Entecavir Preparations Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Entecavir Preparations Sales Quantity by Type (2018-2029)
5.2 Global Entecavir Preparations Consumption Value by Type (2018-2029)
5.3 Global Entecavir Preparations Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Entecavir Preparations Sales Quantity by Application (2018-2029)
6.2 Global Entecavir Preparations Consumption Value by Application (2018-2029)
6.3 Global Entecavir Preparations Average Price by Application (2018-2029)
7 North America
7.1 North America Entecavir Preparations Sales Quantity by Type (2018-2029)
7.2 North America Entecavir Preparations Sales Quantity by Application (2018-2029)
7.3 North America Entecavir Preparations Market Size by Country
7.3.1 North America Entecavir Preparations Sales Quantity by Country (2018-2029)
7.3.2 North America Entecavir Preparations Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Entecavir Preparations Sales Quantity by Type (2018-2029)
8.2 Europe Entecavir Preparations Sales Quantity by Application (2018-2029)
8.3 Europe Entecavir Preparations Market Size by Country
8.3.1 Europe Entecavir Preparations Sales Quantity by Country (2018-2029)
8.3.2 Europe Entecavir Preparations Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Entecavir Preparations Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Entecavir Preparations Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Entecavir Preparations Market Size by Region
9.3.1 Asia-Pacific Entecavir Preparations Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Entecavir Preparations Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Entecavir Preparations Sales Quantity by Type (2018-2029)
10.2 South America Entecavir Preparations Sales Quantity by Application (2018-2029)
10.3 South America Entecavir Preparations Market Size by Country
10.3.1 South America Entecavir Preparations Sales Quantity by Country (2018-2029)
10.3.2 South America Entecavir Preparations Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Entecavir Preparations Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Entecavir Preparations Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Entecavir Preparations Market Size by Country
11.3.1 Middle East & Africa Entecavir Preparations Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Entecavir Preparations Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Entecavir Preparations Market Drivers
12.2 Entecavir Preparations Market Restraints
12.3 Entecavir Preparations Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Entecavir Preparations and Key Manufacturers
13.2 Manufacturing Costs Percentage of Entecavir Preparations
13.3 Entecavir Preparations Production Process
13.4 Entecavir Preparations Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Entecavir Preparations Typical Distributors
14.3 Entecavir Preparations Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Entecavir Preparations Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Entecavir Preparations Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Entecavir Preparations Product and Services
Table 6. Bristol-Myers Squibb Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bristol-Myers Squibb Recent Developments/Updates
Table 8. Qilu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Qilu Pharmaceutical Co., Ltd Major Business
Table 10. Qilu Pharmaceutical Co., Ltd Entecavir Preparations Product and Services
Table 11. Qilu Pharmaceutical Co., Ltd Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 13. Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Major Business
Table 15. Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Entecavir Preparations Product and Services
Table 16. Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Guangzhou Bositao Controlled-release Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 19. JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Major Business
Table 20. JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Entecavir Preparations Product and Services
Table 21. JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO., LTD. Recent Developments/Updates
Table 23. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Major Business
Table 25. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Entecavir Preparations Product and Services
Table 26. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
Table 28. Suzhou Dawnrays Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Suzhou Dawnrays Pharmaceutical Co., Ltd. Major Business
Table 30. Suzhou Dawnrays Pharmaceutical Co., Ltd. Entecavir Preparations Product and Services
Table 31. Suzhou Dawnrays Pharmaceutical Co., Ltd. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Suzhou Dawnrays Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 33. Fujian Cosunter Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Fujian Cosunter Pharmaceutical Co.,Ltd. Major Business
Table 35. Fujian Cosunter Pharmaceutical Co.,Ltd. Entecavir Preparations Product and Services
Table 36. Fujian Cosunter Pharmaceutical Co.,Ltd. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Fujian Cosunter Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 38. Shandong Lukang Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Shandong Lukang Pharmaceutical Co.,Ltd. Major Business
Table 40. Shandong Lukang Pharmaceutical Co.,Ltd. Entecavir Preparations Product and Services
Table 41. Shandong Lukang Pharmaceutical Co.,Ltd. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shandong Lukang Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Aurobindo Pharma Major Business
Table 45. Aurobindo Pharma Entecavir Preparations Product and Services
Table 46. Aurobindo Pharma Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Aurobindo Pharma Recent Developments/Updates
Table 48. Teva Basic Information, Manufacturing Base and Competitors
Table 49. Teva Major Business
Table 50. Teva Entecavir Preparations Product and Services
Table 51. Teva Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Teva Recent Developments/Updates
Table 53. Hainan Zhonghe Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Hainan Zhonghe Pharmaceutical Co., Ltd Major Business
Table 55. Hainan Zhonghe Pharmaceutical Co., Ltd Entecavir Preparations Product and Services
Table 56. Hainan Zhonghe Pharmaceutical Co., Ltd Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hainan Zhonghe Pharmaceutical Co., Ltd Recent Developments/Updates
Table 58. Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Major Business
Table 60. Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Entecavir Preparations Product and Services
Table 61. Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Entecavir Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zhejiang Huasheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 63. Global Entecavir Preparations Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Entecavir Preparations Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Entecavir Preparations Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Entecavir Preparations, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Entecavir Preparations Production Site of Key Manufacturer
Table 68. Entecavir Preparations Market: Company Product Type Footprint
Table 69. Entecavir Preparations Market: Company Product Application Footprint
Table 70. Entecavir Preparations New Market Entrants and Barriers to Market Entry
Table 71. Entecavir Preparations Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Entecavir Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Entecavir Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Entecavir Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Entecavir Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Entecavir Preparations Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Entecavir Preparations Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Entecavir Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Entecavir Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Entecavir Preparations Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Entecavir Preparations Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Entecavir Preparations Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Entecavir Preparations Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Entecavir Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Entecavir Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Entecavir Preparations Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Entecavir Preparations Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Entecavir Preparations Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Entecavir Preparations Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Entecavir Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Entecavir Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Entecavir Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Entecavir Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Entecavir Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Entecavir Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Entecavir Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Entecavir Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Entecavir Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Entecavir Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Entecavir Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Entecavir Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Entecavir Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Entecavir Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Entecavir Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Entecavir Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Entecavir Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Entecavir Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Entecavir Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Entecavir Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Entecavir Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Entecavir Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Entecavir Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Entecavir Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Entecavir Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Entecavir Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Entecavir Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Entecavir Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Entecavir Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Entecavir Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Entecavir Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Entecavir Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Entecavir Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Entecavir Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Entecavir Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Entecavir Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Entecavir Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Entecavir Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Entecavir Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Entecavir Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Entecavir Preparations Raw Material
Table 131. Key Manufacturers of Entecavir Preparations Raw Materials
Table 132. Entecavir Preparations Typical Distributors
Table 133. Entecavir Preparations Typical Customers
List of Figures
Figure 1. Entecavir Preparations Picture
Figure 2. Global Entecavir Preparations Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Entecavir Preparations Consumption Value Market Share by Type in 2022
Figure 4. Tablet Examples
Figure 5. Capsule Examples
Figure 6. Dispersible Tablets Examples
Figure 7. Other Examples
Figure 8. Global Entecavir Preparations Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Entecavir Preparations Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Entecavir Preparations Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Entecavir Preparations Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Entecavir Preparations Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Entecavir Preparations Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Entecavir Preparations Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Entecavir Preparations Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Entecavir Preparations by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Entecavir Preparations Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Entecavir Preparations Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Entecavir Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Entecavir Preparations Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Entecavir Preparations Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Entecavir Preparations Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Entecavir Preparations Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Entecavir Preparations Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Entecavir Preparations Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Entecavir Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Entecavir Preparations Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Entecavir Preparations Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Entecavir Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Entecavir Preparations Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Entecavir Preparations Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Entecavir Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Entecavir Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Entecavir Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Entecavir Preparations Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Entecavir Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Entecavir Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Entecavir Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Entecavir Preparations Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Entecavir Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Entecavir Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Entecavir Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Entecavir Preparations Consumption Value Market Share by Region (2018-2029)
Figure 55. China Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Entecavir Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Entecavir Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Entecavir Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Entecavir Preparations Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Entecavir Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Entecavir Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Entecavir Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Entecavir Preparations Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Entecavir Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Entecavir Preparations Market Drivers
Figure 76. Entecavir Preparations Market Restraints
Figure 77. Entecavir Preparations Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Entecavir Preparations in 2022
Figure 80. Manufacturing Process Analysis of Entecavir Preparations
Figure 81. Entecavir Preparations Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の非経口栄養剤用脂肪乳剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のデゾシン注射市場2023年：企業・地域・タイプ・用途別分析
  • 世界の医薬品用ロプロミド市場2023年：企業・地域・タイプ・用途別分析
  • 世界のチロゲン&バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界の医薬品用ラバーソル市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7844 )"世界のエンテカビル製剤市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Entecavir Preparations Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。